PCHi Technology Summit 2018 Empowers Attendees with Fresh Perspectives
Sep 05, 2018

Beijing, 5 September 2018 --( ASIA TODAY )-- After a successful inaugural run in Shanghai last year, the PCHi Technology Summit returned to the favorable reception of the industry once again. Held from 27 – 28 August at the luxurious W Guangzhou in China, the event attracted around 500 beauty and personal care trade professionals (up almost 50% from last year) in attendance and over 20,000 views online.

This year’s Summit agenda was carefully curated by PCHi’s Cosmetics Science and Technology Innovation Committee (CSTIC), around the theme of Empowered for Renewed Vitality and PCHi’s new key branding pillars of Technology • Power • Spirit. For this edition, organizers chose to focus on the hot topics of anti-aging and sensitive skin, and their main objective was to provide inspiration for industry players to drive technological innovation and research development.

To address attendees’ needs and concerns, speakers not only tackled broad issues such as global market forces, industry trends, and changes in regulatory framework, but they also covered in-depth discussions on formulation technologies, efficacy evaluation, and clinical mechanisms.

Speaking at the event’s opening address, Mr Ying Jun, Vice President, RSE, shared, “According to industry sources, China’s cosmetic market is forecasted to be valued at RMB 490 billion by 2019. Analysts expect great growth potential in the Chinese personal care and home care industry, and this reflects our market’s importance in the global context. Over the last 11 years, our team has been focused on promoting technological innovation, and the PCHi brand is now widely recognized as the industry’s platform of choice — whether for sourcing, networking, or learning. As the personal care and beauty industry continues on its relentless pursuit for excellence, we look forward to making a positive impact by enabling businesses to soar to greater heights.”

Leaders from the China Association of Fragrance Flavour and Cosmetic Industries (CAFFCI), China Cleaning Industry Association (CCIA), and China Research Institute of Daily Chemical Industry (RIDCI) also expressed their views on the industry’s current situation and future trends. Mr Chen Shaojun, President of CAFFCI revealed, “According to our statistics, over 4,500 cosmetics companies in China have obtained production qualifications as at July 2018, and they account for nearly RMB 320 billion worth of products manufactured last year. Market segmentation by specific claims has helped to boost our country’s cosmetics manufacturing sector significantly.”

Sculpting a Brighter Future Together

China’s personal care market is at a point of inflexion and analysts see huge potential for advancement in the years ahead. At the Summit, various industry leaders took the opportunity to share their views on growth strategies for domestic enterprises.

A sentiment that surfaced several times was a reminder for companies to focus more on the big picture — how one can contribute to driving the industry forward and upward — and less on short-term gains, monetary or otherwise. In particular, even as the industry seeks to meet the consumer’s ever-evolving demands, speakers encouraged businesses to ensure two fundamental building blocks are handled well: technological innovation and product safety.

Delegates were exposed to multiple facets of each hot topic as they got to hear from a mixture of subject matter experts — including a dermo-cosmetics clinician, scientist, formulator, product designer, research analyst, regulatory authority, and academia.

Apart from the plenary sessions, Summit delegates were also able to discover some of the latest offerings presented by more than 30 exhibitors.

Similar to last year’s event, selected sessions of the Summit were streamed live so as to benefit the industry at large. Trade professionals who were unable to attend the event can now view the recordings at http://shangzhibo.tv/watch/4385149.

Recognizing Industry Partners’ Contributions
At the event, RSE also took the opportunity to recognize 27 long-standing partners that have made significant contributions to the global personal care and home care industry. These distinguished partners include trade associations, market research firms, trade media, and industry suppliers.

  1.       BASF (China) Company Limited
  2.       Connell Bros. (Shanghai)Co. Ltd.
  3.       Cosfa International Trading (Guangzhou) Co., Ltd.
  4.       Croda China Trading Co., Ltd
  5.       DKSH (Shanghai) Ltd.
  6.       DSM Nutritional Product Asia Pacific
  7.       Evonik Specialty Chemicals (Shanghai) Co., Ltd.
  8.       Guangdong BioMax Si&F New Material Co., Ltd.
  9.       Guangzhou CDLUNION Biotechnology Co., Ltd
  10.     Guangzhou DX Chemical Co., Ltd.
  11.     Guangzhou Jiahua Chemical Co., Ltd.
  12.     Guangzhou Tinci Materials Technology Co., Ltd.
  13.     Hunan Silok Silicone Co., Ltd.
  14.     Sethic Innovation Labo
  15.     Shin-Etsu Silicone International Trading (Shanghai) Co., Ltd
  16.     Symrise Shanghai Ltd
  1.     China Association of Fragrance Flavor and Cosmetics Industries
  2.     China Cleaning Industry Association
  3.     China Research Institute of Daily Chemical Industry
  4.     European Union Chamber of Commerce in China
  5.     Euromonitor International
  6.     Mintel
  7.     China Cosmetics Review
  8.     Colour Cosmetics
  9.     Cosmetics & Personal Care
  10.     Cosmetics Business Online
  11.     Cosmetics Newspaper


Next Stop: PCHi 2019

The 12th edition of PCHi will be held from 26 to 28 February 2019 at the Guangzhou Poly World Trade Center, China.

Pre-register online for complimentary visitor access athttp://www.pchi-china.com/en/Visitors/Visitor-Registration/ before 12.00am (GMT+8) on 22 February 2019.

For more information about PCHi 2019, please visitwww.pchi-china.com/en, or connect with PCHi on social media.


About PCHi

The Personal Care and Homecare Ingredients (PCHi) trade show is China's #1 Sourcing Platform for the Global Personal Care Industry. As an innovation-led event, PCHi provides cosmetics, home and personal care manufacturers, ingredients suppliers, cosmetics packaging, machinery and product testing providers from all over the world with a quality platform for ingredients sourcing, gaining insight into global trends, and networking with world-class experts.

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Cadrock Secures US$5m for Therapy Targeting $35 billion Heart Disease Market
JCN Newswire
Sep 03, 2018

- Enrolls first clinical trial patients in Sydney, Australia

SYDNEY - (ACN Newswire) - Cadrock Pty Ltd, which owns an investigational prevention and treatment therapy for coronary artery disease (CAD), has secured a US$5 million seed investment from a Chinese investor to fund clinical trials.

Cadrock is potentially disrupting the entire heart-care sector by proposing CAD is caused by bacterial infection.

Cadrock data is backed by a clinical trial treating CAD as an infection with an antibiotic therapy in London, UK, which demonstrated a 36% reduction in Major Cardiac Events (MCEs) (STAMINA).

"Where there is inflammation, look for infection," says Professor Borody, who is well known globally for discovering the cure for the peptic ulcer bacterial infection, using a triple antibiotic therapy.

His triple antibiotic therapy for peptic ulcers prevented 18,655 premature deaths and saved the Australian Government an estimated AU$10.03 billion (THEMA Report).

Professor Borody has now developed and patented a new investigational triple antibiotic therapy to combat the infection believed to cause CAD.

"The Cadrock therapy is targeting the $35 billion CAD market and is the only therapy focused on the cause of CAD rather than suspected risk factors," said Professor Borody.

The first Cadrock interventional clinical trial of the triple therapy at Liverpool Hospital, Sydney Australia, has just enrolled its second patient.

The study is recruiting 60 people with CAD and will "evaluate the effect of antibiotic combination therapy on objective measures of improvement in coronary flow as determined by fractional flow reserve (FFR) intra-coronary imaging (Intravascular ultrasound [IVUS] and/or Optical Coherence Tomography [OCT]) in subjects undergoing percutaneous coronary intervention (PCI) with non-critical lesions in non-culprit arteries."

Professor Borody is most famous for discovering the triple antibiotic therapy for peptic ulcers in 1985, after Nobel Prize recipients Barry Marshall and Robin Warren discovered infection as the cause.

Professor Borody said, "CAD heart disease and stroke are the world's biggest killers with around 15 million deaths in 2015. In the US alone heart disease is the leading cause of death for both men and women - 610,000 people die of heart disease in the United States annually. (Source: CDC).

In China, about 230 million or 1/5 people have cardiovascular disease. (Source: Harvard University)

Additionally, peripheral vascular disease worldwide afflicts around 200 million people.

Statins form part of the first line treatment of CAD but reduce Major Cardiac Events (MCEs) in preventative studies by as little as 0.2-0.6%. (Jupiter)

About Cadrock

Cadrock Pty Ltd has a novel investigational prevention and treatment therapy for coronary heart disease (CAD) developed by Professor Thomas Borody, who discovered the cure for peptic ulcers. The Cadrock therapy is targeting the $35 billion CAD market and is the only therapy focused on the cause of CAD, rather than suspected risk factors. The Cadrock therapy is now in clinical trials in Australia. For more information, and access to the Digify investor VDR, please contact investor relations at IR@Cadrockacac.com.

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Company JCN Newswire
Contact Tiara Liu
Telephone +81-3-5791-1821
E-mail info@japancorp.net
Medical Devices ASEAN 2018 welcomed 3,639 trade visitors from 31 countries
Aug 30, 2018

The first edition of Medical Devices ASEAN 2018 ("MDA 2018"), the international exhibition and congress on medical devices, technologies, services and general healthcare, reflected its success as the gateway to ASEAN’s medical devices industry. Over 125 brands and companies from 10 countries alongside more than 3,639 national and international trade visitors from 31 countries gathered, to explore this new chapter in ASEAN’s medical devices industry; raising the bar for medical devices standards and supporting the push to position Thailand as the medical hub of ASEAN.

MDA 2018 as an integrating platform for medical devices industry
Mr. Loy Joon How, General Manager, IMPACT Exhibition Management Co., Ltd. (“IMPACT”), said, “The first edition of MDA 2018 exceeded our expectations due to strong supports from the public and private sectors. This event showcased the latest medical innovations and technologies, covering a comprehensive range of products and services, including general surgery; orthopedic surgery and rehabilitation medicine; radiology and diagnostic imaging; medical laboratory; IT in healthcare; medical instruments and consumables.”

Mr. Veerasith Sinchareonkul, Executive Director, Sri Trang Gloves (Thailand) Co., Ltd., who exhibited at MDA 2018, stated, “We are a major player in the medical and healthcare industry and we recognized MDA 2018 as a vital event for the industry. We exhibited at the event to contribute to the expansion of Thailand’s medical device market. Exhibiting at MDA 2018 served as a public relations tool to increase the awareness of our business, enhance our reputation, and present our products to our customers. This show is an all-encompassing medical devices exhibition in the region."

"We believe that MDA 2018 is an effective platform for us to link up with other potential partners. The feedback from the attendees is quite positive, and the show is fabulous," added by Jack Cheung, a representative from Logital Co., Ltd., Hong Kong.

The MDA Congress, with six academic conferences and an industry forum, welcomed over 1,559 delegates. Attended by lab professionals, doctors, general practitioners, orthopaedists, nurses, radiologists, radiographers, biomedical engineers and other specialists, the sessions were strongly supported by the Royal College of Orthopaedic Surgeons of Thailand; the Nurses’ Association of Thailand under the Royal Patronage of Her Royal Highness the Princess Mother; the Radiological Society of Thailand; the Thai Association for Medical Instrumentation; the Thai Medical Informatics Association; the Association of Medical Technologists of Thailand under the Patronage of H.R.H. Princess Soamsawali; and the Thai Medical Device Technology Industry Association

Mr. Loy concluded, “Under the theme ‘Building the Future of Healthcare’, MDA aimed to serve as an integrated healthcare platform to facilitate business among manufacturers, suppliers, and end-users; and to offer valuable insights into the healthcare market in ASEAN. We look forward to a more vibrant and comprehensive edition next year and we are very excited to facilitate these companies’ journey to establish and expand their presence in the ASEAN’s medical devices industry.”

The second edition of MDA will be held on 10-12 July 2019, at Hall 1-2, IMPACT Exhibition Center, Bangkok, Thailand.

For more information on the definitive exhibition, please visit www.medicaldevicesasean.com

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Company Impact
Telephone +662 833 5308
Mega Oncology Conference successfully held at Shenyang’s EXPO
Aug 28, 2018

Shenyang, 27 August 2018 --( ASIA TODAY )-- The Shenyang New World EXPO (“EXPO”) successfully hosted one of the largest Chinese international conferences ever to be held in northeast China. The 2018 Chinese Conference on Oncology was held on 18-19 August.

Delegate attendance on the opening day of the Conference exceeded 18,000. The event maximized the use of all areas of the venue including the 24,000 sqm (258,000 sq. ft.) of exhibition/multi-purpose space and 4,000 sqm (43,000 sq. ft.) of meeting space.

During the 2 day event, the venue provided F&B services as well as venue safety and security services to ensure efficient crowd management and transportation logistics. Shenyang’s Security and Traffic Bureaus were also outstanding in their support of the staff and event.

EXPO General Manager Diane CHEN said, “This extraordinary mega-conference was a real challenge due to the attendance and technical details. Its success is a credit again to the tremendous commitment of our EXPO staff and the superb cooperation received from our government bureaus. We have shown again how valuable EXPO can be to the community in hosting such events which will only add significantly to the positive economic impact of the city and Liaoning Province.”

Shenyang New World EXPO Venue Management Chairman Cliff Wallace acknowledged the leadership provided by EXPO’s management and the standards by which the organizers planned and executed the Conference. It was an endorsement of the venue, the city and the government. With such ongoing cooperation, Wallace said, “The meeting and exhibition industry of Shenyang and Liaoning can only expect healthy growth.”

The Conference was sponsored by China Anti-Cancer Association (CACA), and organized by Liaoning Cancer Hospital & Institute and Liaoning Anti-Cancer Association. The Conference also enjoyed the highest number of attending academicians, collected papers and participating experts of any of its previous conferences.

The Conference set-up included 1 main venue, 8 theme venues and 77 parallel sessions holding academic forums with 923 renowned scholars and experts specialized in oncology across the world. The number of people watching live broadcast online reached 1.08 million, involving 210 media outlets.

The Conference included parallel sessions to discuss new ideas, new techniques and new methods concerning common treatment like radiotherapy and chemotherapy, anti-cancer drugs, Minimally Invasive Surgery (MIS) and Percutaneous Coronary Intervention (PCI), therapeutic endoscopy, biotherapy, nutritional oncology, nuclear medicine, and psycho-oncology and oncologic nursing, as well as exchange opinions on development of pathology of neoplasia, tumor markers, epidemic diseases and etiology of cancers.

For more information, please contact:

Diane CHEN - dianechen@shenyangnwexpo.com or
Cliff WALLACE - cliffwallace@hkcec.com

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

2018 Healthcare+ Expo Taiwan Where Tech Meets Medicine
Aug 16, 2018

TAIPEI, Taiwan--(BUSINESS WIRE)--From November 29th to December 2nd 2018, global-leading biomedical and technology institutes will gather in Taipei for the top healthcare and technology event in Asia - The Healthcare+ Expo - Taiwan. In line with the theme “Med X Tech”, a lineup of global leaders in technology will share the latest technology advancements and how technology create better solutions for future medical applications.

This year, the expo gathers 400 + world-class medical institutes and multi-national IT/ICT/electronic giants. The IT giants will showcase medical innovations of AI, IoT and robotic technologies. The medical institutes will demonstrate advanced medical technologies, smart hospital designs, products, and services while bio-pharmaceutical, medical device, and genetic enterprises will provide the most current updates in precision medicine. In all, more than 1,400 booths will cover the entire healthcare ecosystem from prevention to treatment and aftercare.

Furthermore, Taiwan’s leading tech players, including: Foxconn, BenQ, Asus, Wistron, and Quanta, have been actively diversifying their businesses into healthcare; while AI pioneers, including Google, Microsoft, and Nvidia, have all announced the establishment of AI centers to develop projects focusing on medical applications in Taiwan this year. With world-class healthcare system, well-established clinical data resources, an impressive number of tech and medical professionals, Taiwan is now a new hub for digital healthcare in Asia.

Healthcare+ Expo Taiwan is a signature expo in Asia Pacific that bridges interdisciplinary collaborations between medicine, IT/electronics, and bio-pharmaceuticals. Aligning with the latest healthcare trends to foster collaborations between tech and healthcare, the expo will feature the following events:

Med X Tech Summit Asia: Foresee the future of healthcare

This international summit gathers global leaders to discuss the future trends of the healthcare industry. Topics include AI, IoT, Blockchain, precision medicine, regenerative medicine and more. Attendees will be exposed to the latest technological breakthroughs in healthcare.

Bio Innovation Stadium: A spotlight on disruptive innovations

This event features presentations by biomedical innovators from Israel, Australia, the U.S., France, Korea, and Singapore on topics from technologies that disrupt current care models to innovations that accelerate the advancement of the health industry. Join us to explore opportunities and strategies for biomedical innovations and investments.

Institute for Biotechnology and Medicine Industry
Research Center for Biotechnology and Medicine Policy
Gordon Shen, PhD, +886-2-2655-7888
David Yang, PhD, +886-2-2655-8168

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Dubai Hosts 10th UAE Cancer Congress this October
Aug 15, 2018

“According to Gulf Cancer Monitoring Center, 21,000 new cancer cases are predicted among GCC nationals by 2030”

Dubai – United Arab Emirates, 15 August, 2018: Held under the patronage of His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, Cabinet Minister and Minister of Tolerance, United Arab Emirates and President of UAE Genetic Disease Association, Dubai is set to host the 10th UAE Cancer Congress – UAECC, an event dedicated to oncology professionals in Dubai and focusing on a broad range of topics in Oncology Care and Management, from the 11th to the 13th of October 2018, at the InterContinental Dubai Festival City.

In its 10th edition, UAECC aims to foster best practices in cancer care and management, raise treatment standards at the clinicians’ level for better patient care, discuss latest advances in cancer care, research studies and new treatment methodologies for various cancer diseases.

This year, the UAECC, held under the theme ‘Promoting Excellence in Oncology and Striking away Cancer’, will feature a wide range of sessions on over 14 different oncology sub-specialties focusing on Breast Cancer, Gastrointestinal (GI) Cancer, Gynecological Oncology, Lung Care, Oncology Nursing, Palliative Care, Immuno Oncology and Head & Neck Master Course while also holding dedicated workshops on Breast Surgical Oncology, Cancer Imaging, Nutrition and Live Operative Workshop – From Tata Memorial Hospital, India.

During the 3-day event, UAECC is expected to attract over 2500 visitors and more than 40 participating sponsor companies, witness the participation of more than 200 speakers from over 75 countries, feature 17 hands-on workshops including a ‘Live Workshop from Tata Memorial hospital in India’ and showcase over 200 poster presentations designed by students and professionals from the UAE and abroad.

Commenting on the significance of the 10th UAE Cancer Congress in Dubai, Dr. Shaheenah Dawood, President, UAECC, Consultant Medical Oncologist, Mediclinic City Hospital, UAE said, “Our mission at UAE Cancer Congress is to play a crucial part in preparing the community for overcoming issues and challenges in preventing the onset of cancer. As part of our efforts in effectively overcoming this disease in the Middle East and Asia Pacific region, we strive to support the oncology community by partnering, learning and building collaborations with various organizations and coming up with unique initiatives to allow for progress in cancer research. Furthermore, UAECC is the only such congress in the middle east, which has been consistently bringing cutting edge medical research and technology to our doorsteps in the past 10 years.”

She added, “Cancer treatment is undergoing a revolution where the influx of novel therapies derived from basic research on our immune system has shifted the landscape of modern medicine. In addition, new discoveries in immunotherapy, which seek to use the body’s immune system to help fight cancer, are proving to have a profound impact on cancer treatment and prevention. As research and the development of new therapies for different types of cancers is a continuous process requiring great effort, we believe that UAECC is an ideal platform which will serve the needs of the medical and pharmaceutical industry in overcoming this disease.”

UAECC 2018 will be introducing the 1st Asia Pac Middle East Biosimilar Summit on the sidelines of its main conference, with the aim of building a viable roadmap on the advantages of using biosimilar pharma products as compared to generic drugs while also offering industry experts an opportunity to discuss the pros & cons and misconceptions about biosimilar pharmaceutical products, exchange latest data from the ‘Global Biosimilars Landscape’, explore Case Studies and support pharma and Biopharma companies to succeed in the Global Biosimilar Market.

Cancer Stats in the Gulf region:

While the world of medicine has made rapid strides and great progress in our understanding about cancer and its prevention, cancer still remains the most threatening challenge for medical fraternity, communities and peoples without exception. According to the Gulf Cancer Monitoring Center, it is predicted that 21,000 new cancer cases will occur among GCC nationals by 2030, while the number of cancer cases were 8065 in 1998 and 11,894 in 2009. More figures released by the Health Department of Abu Dhabi show that there are 4,500 new cases of cancer each year, with breast, colorectal and lung cancers, widely impacting patients in the region.

The 10th UAECC, being held until the 13th of October, is organized by INDEX Conferences and Exhibitions – a member of INDEX Holding in partnership with UAE Genetic Disease Association, Oncology Nursing Society, Emirates Urological Society, Tata Memorial Centre and Indian Cooperative Oncology Network, India.

-End -

Suzan Mounzer
Public Relations & Social Media Manager
Tel: +971 45208888
Mob: +971 569070443
E-mail: suzan.mounzer@index.ae

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Union Medical Healthcare and Biotechnology Company Avalon Genomics Agree to Strategic Collaboration
Jul 31, 2018

(30 July 2018, Hong Kong) Union Medical Healthcare Limited ("Union Medical Healthcare" or the "Company", together with its subsidiaries, the "Group", SEHK stock code: 2138), a leading integrated medical group in Hong Kong, is pleased to announce that the Group has entered into a strategic collaboration agreement with Avalon Genomics (HK) Limited ( "AGHK"), which is wholly owned by Avalon Genomics Limited ("Avalon Genomics"), expanding its services to genetic testing.

Avalon Genomics is a biotechnology company primarily engaged in the business of genetic laboratories, genetic testing and related development and research. Pursuant to the Agreement, AGHK granted the Company the exclusive right in the health check business sector in Hong Kong, subject to the terms of the Agreement, to distribute, promote, market and sell the genetic and genomic tests developed and offered by AGHK, which assess the genetic risks for various diseases of human beings including but not limited to autoimmune diseases, cancers, heart and vascular diseases, metabolic diseases and respiratory diseases. Meanwhile, the Group has entered into an agreement to acquire a minority stake in Avalon Genomics as a strategic investor.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of Union Medical Healthcare, said, "The Group has been extending its reach to and investment in other medical disciplines to enhance its service portfolio offering. We are pleased that Avalon Genomics has granted the exclusive right and agreed to work in strategic collaboration with us. Avalon Genomics is founded by a group of reputable scientists, biotechnologists and medical doctors who share a vision of people advancing healthcare of society through novel genetic research. Their vision coincides with our core values about developing precision medicine and preventive medical services. Through the collaboration, both Avalon Genomics and Union Medical Healthcare will be able to create synergy by leveraging our respective talents and resources, thus delivering a full array of quality services to clients."

- End -

About Union Medical Healthcare Limited
Union Medical Healthcare is principally engaged in the provision of one-stop medical and health care services in the Greater China via its 54 clinics and servicing centres with an aggregate service floor area of 200,000 sq. ft. The Group provides a full range of services and products under our well-recognised brands, including those of its one-stop aesthetic medical solutions provider DR REBORN, chiropractic services centre SPINE Central, health management and vaccination centre re:HEALTH and comprehensive dental centre UMH DENTAL CARE. Of which DR REBORN is recognised by "Hong Kong Top Service Brand Award" that is jointly organised by Hong Kong Brand Development Council and The Chinese Manufacturers' Association of Hong Kong. The Group is the largest aesthetic medical service provider in Hong Kong in terms of revenue in 2017.

For further information, please contact:
iPR Ogilvy & Mather
Callis Lau / Molisa Lau / Maggie Chui / Francesca Yeung
Tel: (852) 2136 6952 / 2136 6953 / 2136 8059 / 3920 7639
Fax: (852) 3170 6606
Email: umh@iprogilvy.com

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Kimchi, a well-known traditional fermented Korean food, has proven effective against influenza virus
Jul 26, 2018

- Lactic acid bacteria, green onion and ginger in kimchi serve as natural antiviral agents, highly effective in preventing influenza.
- Kimchi has the greatest antiviral effect when it is the most delicious (best fermentation periods).
- When the SARS epidemic swept China, some argued that kimchi had safeguarded Koreans against the epidemic.
- A joint research team from the Korea Food Research Institute and the World Institute of Kimchi proved kimchi's effectiveness against flu for the first time in the world.

SEOUL, South Korea, July 26, 2018 /PRNewswire/ -- Kimchi, a well-known traditional fermented Korean food, is highly effective in preventing influenza virus in winter, according to the results of cell·animal experiments.

A joint research team from the Korea Food Research Institute and the World Institute of Kimchi recently announced that lactic acid bacteria and fermentation metabolites in kimchi inhibit the growth of influenza virus -- proving kimchi's effectiveness against flu for the first time in the world, along with the genetic information of strains(metagenome), fermentation metabolites, and bioactive mechanism.

Flu viruses are pathogens that cause acute respiratory conditions in winter. Swine flu (influenza A), which struck the world in 2009, and avian influenza (AI), which recently infected poultry in some countries, are two strains of influenza viruses. Due to mutation of virus, the prevention of flu from these kinds of viruses is so difficult, and infections caused by them are difficult to treat as well.

The research team, which consists of Dr. Kim, In-Ho (Korea Food Research Institute), Dr. Choi, Hak-Jong (World Institute of Kimchi), Korea University College of Medicine, and Dr. Ryu, Byung Hee (Daesang Corp., one of the leading food producers in Korea), collected kimchi samples at each fermentation stage (less-fermented, well-fermented, and over-fermented) and injected them into flu virus-infected cells and animals.

In this study, extracts from the kimchi sample at the 'well-fermented' stage (about 3-7 days after kimchi is made, when kimchi tastes best) were administered to cells infected with the influenza virus (H1N1) and the avian influenza virus (H7N9). In all of the cells, plaque formation significantly reduced, which means that the growth of the flu virus had been inhibited.

In the animal experiment where flu virus-infected mice were fed kimchi extracts, the rate of suffering from weight loss due to the flu also declined. In addition, the survival rate of the mice who consumed kimchi extracts was 30% higher than those who did not.

Dr. Kim, In-Ho of Korea Food Research Institute said, "Lactobacillus plantarum, which is produced in large quantities during the fermentation of kimchi, and its sub-ingredients such as green onion and ginger are thought to hinder the growth of influenza virus. We concluded that bioactive compounds from lactic acid bacteria produced by kimchi fermentation serve as antiviral agents by affecting the virus membrane surface or promptly activating immune cells mobilization." He added, "Our study is the world's first that scientifically verified kimchi's effectiveness against influenza viruses such as swine flu and AI viruses.

In addition, we succeeded in isolating useful and safe lactic acid bacteria from kimchi, contributing to broadening its industrial applications. In other words, this can be applied not only to fermented foods including kimchi, paste, and liquors but also to animal feeds, and food and drug materials. It can also lay the milestone for the development of fermented foods and strains optimized for the constitution of Koreans, through analysis of microbial genome and metabolites in fermented foods as well as mechanism. As such, we have launched new food products in partnership with Daesang corp, aiming to contribute to safeguarding Koreans against virus threats of modern society and to strengthening Korea's competitiveness as the birthplace of kimchi."

In 2003, SARS (Severe Acute Respiratory Syndrome) was pandemic in many parts of the world including Hong Kong and mainland China, except for Korea where very few people were infected with the virus. Regarding this, some argued that kimchi has an antiviral effect. The results of the study (Effects of heat-killed Lactobacillus plantarum against influenza viruses in mice) were published in the February 2018 issue of the Journal of Microbiology.

Photo by Jakub Kapusnak on Unsplash

Source: World Institute of Kimchi

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

66 Scientific Sessions & 40 Top-Notch Speakers in the Premier Radiology Event this October
Jul 18, 2018

Dubai – United Arab Emirates, 18 July 2018: Dubai is all set to host the 3rd edition of the Annual Radiology Meeting in UAE(ARM), from the 31st of October to the 2nd of November this year at the Dubai International Convention and Exhibition Centre. Held under the patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of Dubai Health Authority, the Annual Radiology Meeting in UAE is considered a premier radiology event in the MENA region, dedicated to radiologists, radiographers and specialists in the field.

The event presents this year a number of new scientific activities like dedicated radiographer sessions, poster presentation competition to support scientific research, a dedicated panel discussion on AI entitled “Will Artificial Intelligence replace radiologists in the future?”, and the Emirates Radiology Cup for the best scientific case presented. The conference this year also focuses on Pediatric Imaging by dedicating a 1 day seminar on this topic presented by the Middle East Society of Pediatric Radiology.

In addition to that, the conference features a rich scientific agenda that covers 66 scientific sessions and lectures that will educate the attendees on various aspects of radiology and imaging, creating a great platform for knowledge exchange amongst conference participants and professionals in the field.

Over 40 top-notch speakers and 1,700 professionals from different parts of the world will be meeting at ARM 2018 to discuss a number of key trending topics in radiology including: Cardiac Imaging, Emergency Radiology, MSK, Artificial Intelligence in Radiology, Neuroradiology, Chest Imaging, Body Imaging, Pediatric Imaging for General Radiologists and Radiography.

Parallel to the conference, the exhibition attracts more than 50 participating brands in the field of radiology and diagnostic imaging who will showcase their cutting-edge equipment and most updated medical devices used in the field, in addition to key technologies in interventional radiology and Artificial Intelligence (AI) enabled radiological equipment.

Commenting on the importance of this event, Dr. Abdul Salam Al Madani, Executive Chairman, ARM said: “Radiology or diagnostic imaging is integral in medical practice as it paves the way for proper diagnosis and treatment of various diseases. Annual Radiology Meeting in UAE recognizes the need to develop, modernize and attract the best competencies for imaging on par with international standards, and thus the event presents the ultimate platform to share best practices in the profession and discover latest innovation and technology.”

He added: “In line with the Dubai Health Strategy 2016-2021 and the UAE strategy for Artificial Intelligence, which aims to foster the use of technology in the healthcare sector to improve efficiencies, enhance healthcare management and improve patient centric care, ARM will join efforts of the public and private sector to promote the use of AI for diagnostic imaging through the special focus on this topic during the conference this year, while also cater to the needs of 21st century radiologists, who need to adapt to advanced imaging methods and technologies.”

Speaking at the conference this year, Prof. Claude Pierre Jerome, Associate Professor of Radiology, Oslo University, Norway, said: “ARM is an exceptional event in Dubai and presents a unique gathering of radiology experts and academicians from many well-known institutions in the USA, Europe, Asia and the Middle East. This year, my lectures will focus on the diagnostic criteria of Spondylodiscitis on MRI, and secondly on the Biomechanics and Pathologies of the Ankle-Foot Unit including derangements of the Achilles tendon and the Plantar Fascia.”

He added: “Today, the new generation of radiology specialists have developed a keen interest both in radiology and scientific research related to various disciplines in the field. Our main goal at ARM 2018 is to provide a broad range of information not only about everyday radiology practices but also about recent scientific developments in the field.”

It is worth mentioning that the Annual Radiology Meeting in UAE is organized annually by INDEX Conferences and Exhibitions – a member of INDEX Holding in collaboration with the Radiology Society of the Emirates.

- End -

Media Contact
Suzan Mounzer
Public Relations & Social Media Manager
Tel: +971 45208888
Mob: +971 569070443
E-mail: suzan.mounzer@index.ae

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Through the Shifting Clouds of Fears & Worries
Jul 13, 2018

“Doctor, you mean both my kidneys are not functioning at all and I have to be on dialysis for three times a week with each time covering 4 hours for the rest of my life unless there is a possibility of me receiving a healthy donor kidney or advances in medical science?”.

This was a question posed by a bewildered 21 year old Vanitha a/p Veeramugam to the nephrologist standing beside her ward bed in 2004 at the Universiti Malaya Medical Centre (UMMC) in Kuala Lumpur after the doctor had laid down the bare truth as to the cause of her illness.

She was earlier rushed to the medical centre upon an urgent referral by a medical group in Klang where her mother had brought her for treatment following a recurrence of continuous bouts of vomiting, diarrhoea and loss of appetite. 2 weeks prior to the referral she was admitted to the Tengku Ampuan Rahimah Hospital in Klang for observation after she had similar signs of illness. The hospital in Klang after warding her for treatment and observation for a week discharged her.

Alas, she had recovered with dialysis which took much of her working time as an operator in a Japanese company in Shah Alam where she had worked after passing her Sijil Pelajaran Malaysia (SPM) in 2000. Ultimately, after having being on medical leave for finding a diagnosis to her kidney failure and for her dialysis she had to quit her job.

All this while, UMMC carried on in providing dialysis and at the same time advised her family to look for a dialysis centre which charged lesser fees for the treatment. In the midst of such activities, her maternal uncle, in addition to helping pay for the fees in dialysis and medication by the medical centre, managed to secure financial assistance for her from Tzu Chi, a Buddhist Foundation. Later, after a few months he managed to get for her “Pencen Ilat’ under the social security organisation, SOCSO to pay for the dialysis treatment.

In the search for a dialysis centre, there was found a vacancy in Pusat Dialisis NKF – Bakti (Klang) which was near her place of residence. She is indeed very much appreciative of NKF which she said, “gives a high standard of treatment with its staff members creating a family-like atmosphere to bring about a cosy and close relationship among not only the patients but staff members themselves.”

To-date, she has remained single, staying with a married younger sister with 3 children and a husband in Taman Sentosa, Klang. She has declined the offer of her mother donating one of her kidneys to her even though there was found compatibility in the matching of the older woman’s kidney with her body system for she feared for her mother’s suffering in the aftermath of the transplant. However, she would be prepared to accept a compatible kidney from any donor who is a non-relative.

She is now settled in her routine of dialysis and when she is not dialysing she helps her sister in cooking as she loves to cook and keeps herself busy by watching television programmes. For light relaxation, she loves going cycling in the park of the housing estate and treats each passing day as a wonderful gift

Members of the public can pledge to donate their organs with the organ donation promotion unit that the National Kidney Foundation of Malaysia (NKF) had set up at the Sunway Pyramid with the support of the Sunway Group.

For more information on these and future NKF activities or to donate towards the organisation’s efforts, please visit http://www.nkf.org.my or call 03-7954 9048.

- ASIA TODAY News Global Distribution http://www.AsiaToday.com